The 7th World Conference on Targeting Phage Therapy 2024 is scheduled to take place on June 20-21 at Corinthia Palace in Malta. This annual event introduces the latest advancements in the field of phage research and therapy, showcasing how these developments could reshape healthcare practices globally.
The scientific board published the agenda. More than 20 speakers will present their studies and visions.
Access Targeting Phage Therapy 2024 Agenda.
Targeting Phage Therapy 2024 Academic & Industrial Attendees
Among the companies who will take part at the conference: Precision Phage (supporter), PHAXIAM Therapeutics, Rime Bioinformatics, Phage Consulting, Intralytix, Inc., Invitris, MicrobiotiX, Sciensano, Vivantes, Laboratorios Syva, ACD Pharma, and others.
Among academics who will participate: Goethe University Frankfurt, Hannover Medical School, Jena University Hospital, University of Warsaw, University of Warwick, Victor Babes University of Medicine Timișoara, Yale University, Yıldız Technical University, University of Gdansk, University of Helsinki, University of Liverpool, and many more.
Key Questions to be addressed at the Conference
1. What are the latest breakthroughs in phage therapy, and how might they revolutionize treatment protocols in medical practice?
Discover recent innovations that set the stage for new therapeutic strategies.
2. How is the integration of phage therapy in hospitals progressing, and what advancements are being made to make this more feasible?
Explore the transition of phage therapy from research to real-world clinical settings.
3. Considering the ethical implications, how is phage therapy navigating the challenges associated with personalized medicine and patient data privacy?
Gain insights into the ethical considerations critical to the advancement of personalized treatments.
4. In what ways are phages being utilized in agriculture and veterinary medicine, and what are the potential benefits and risks associated with their increased use in these fields?
Learn about the dual impact of phage applications outside human health, particularly in enhancing agricultural productivity and managing animal diseases.
5. How is artificial intelligence accelerating the discovery and development of new phage therapies, and what future innovations can we anticipate from this synergy?
Examine the role of AI in streamlining the research and development process for phage therapy.
6. What are the key factors in scaling up phage production to meet global health demands, and what technological advancements are supporting this growth?
Discuss the logistical and technical challenges in mass-producing phages.
7. How do public perceptions of phage therapy influence its adoption, and what efforts are being made to educate and inform the wider community?
Address the misconceptions and information gaps surrounding phage therapy.
8. Can you share a success story where phage therapy has provided a solution to a multidrug-resistant infection?
Highlight successful case studies that illustrate the effectiveness of phage therapy in combating antibiotic-resistant infections.
9. What international collaborations are currently making significant impacts in phage research, and how do these partnerships foster global health improvements?
Outline the benefits of global research partnerships in advancing phage therapy.
10. What are the regulatory challenges currently facing the phage therapy field, and what are the proposed solutions to address these hurdles?
Discuss the complexities of regulatory frameworks affecting the adoption of phage therapies.
Join us at the 7th World Conference on Targeting Phage Therapy to be part of the conversation that shapes the future of healthcare, agriculture, and veterinary science.
This event is a must-attend for healthcare professionals, researchers, policymakers, and anyone interested in the development of innovative solutions to some of the world’s most persistent health challenges.
Stay Tuned with all Phage Therapy News